1. Home
  2. BLLN vs CTRI Comparison

BLLN vs CTRI Comparison

Compare BLLN & CTRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BLLN

BillionToOne Inc.

N/A

Current Price

$118.17

Market Cap

3.9B

Sector

Health Care

ML Signal

N/A

Logo Centuri Holdings Inc.

CTRI

Centuri Holdings Inc.

HOLD

Current Price

$30.65

Market Cap

3.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLLN
CTRI
Founded
2016
1909
Country
United States
United States
Employees
713
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.2B
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
BLLN
CTRI
Price
$118.17
$30.65
Analyst Decision
Buy
Hold
Analyst Count
7
5
Target Price
$126.71
$29.88
AVG Volume (30 Days)
782.3K
1.1M
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
412.50
EPS
N/A
N/A
Revenue
N/A
$2,982,781,000.00
Revenue This Year
$46.29
$14.62
Revenue Next Year
$30.14
$8.16
P/E Ratio
N/A
N/A
Revenue Growth
N/A
13.10
52 Week Low
$61.96
$19.04
52 Week High
$138.70
$42.99

Technical Indicators

Market Signals
Indicator
BLLN
CTRI
Relative Strength Index (RSI) 67.16 50.14
Support Level $79.07 $27.81
Resistance Level $138.70 $32.09
Average True Range (ATR) 6.87 1.38
MACD 1.10 0.26
Stochastic Oscillator 97.91 63.09

Price Performance

Historical Comparison
BLLN
CTRI

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About CTRI Centuri Holdings Inc.

Centuri Holdings Inc is a pure-play North American utility infrastructure services company that partners with regulated utilities to maintain, upgrade and expand the energy network that powers millions of homes and businesses. Its service offerings consist of the modernization of utility infrastructure through the maintenance, retrofitting and installation of electric and natural gas distribution networks to meet current and future demands while also preparing systems for the transition to clean energy sources. Its reportable segments are: (i) U.S. Gas Utility Services (U.S. Gas); (ii) Canadian Utility Services (Canadian Operations); (iii) Union Electric Utility Services (Union Electric); and (iv) Non-Union Electric Utility Services (Non-Union Electric).

Share on Social Networks: